These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 23687381)

  • 1. Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3σ.
    Aktary Z; Kulak S; Mackey J; Jahroudi N; Pasdar M
    J Cell Sci; 2013 Jul; 126(Pt 14):3031-42. PubMed ID: 23687381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1.
    Aktary Z; Chapman K; Lam L; Lo A; Ji C; Graham K; Cook L; Li L; Mackey JR; Pasdar M
    Oncogene; 2010 Apr; 29(14):2118-29. PubMed ID: 20101217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plakoglobin represses SATB1 expression and decreases in vitro proliferation, migration and invasion.
    Aktary Z; Pasdar M
    PLoS One; 2013; 8(11):e78388. PubMed ID: 24260116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plakoglobin restores tumor suppressor activity of p53
    Alaee M; Nool K; Pasdar M
    Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells.
    Shim JS; Kim DH; Kwon HJ
    Oncogene; 2004 Mar; 23(9):1704-11. PubMed ID: 14661058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
    Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
    Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the oncogenic potential of beta-catenin by the subcellular distribution of plakoglobin.
    Li L; Chapman K; Hu X; Wong A; Pasdar M
    Mol Carcinog; 2007 Oct; 46(10):824-38. PubMed ID: 17415780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond cell-cell adhesion: Plakoglobin and the regulation of tumorigenesis and metastasis.
    Aktary Z; Alaee M; Pasdar M
    Oncotarget; 2017 May; 8(19):32270-32291. PubMed ID: 28416759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
    Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
    Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
    Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
    Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The physical interaction of p53 and plakoglobin is necessary for their synergistic inhibition of migration and invasion.
    Alaee M; Padda A; Mehrabani V; Churchill L; Pasdar M
    Oncotarget; 2016 May; 7(18):26898-915. PubMed ID: 27058623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plakoglobin induces desmosome formation and epidermoid phenotype in N-cadherin-expressing squamous carcinoma cells deficient in plakoglobin and E-cadherin.
    Parker HR; Li Z; Sheinin H; Lauzon G; Pasdar M
    Cell Motil Cytoskeleton; 1998; 40(1):87-100. PubMed ID: 9605974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
    J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2004 Aug; 64(15):5078-83. PubMed ID: 15289308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitofusin-2 is a novel direct target of p53.
    Wang W; Cheng X; Lu J; Wei J; Fu G; Zhu F; Jia C; Zhou L; Xie H; Zheng S
    Biochem Biophys Res Commun; 2010 Oct; 400(4):587-92. PubMed ID: 20804729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
    Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
    Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
    Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
    Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP2alpha alters the transcriptional activity and stability of p53.
    Stabach PR; Thiyagarajan MM; Woodfield GW; Weigel RJ
    Oncogene; 2006 Apr; 25(15):2148-59. PubMed ID: 16288208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.